INOVIO PHARMACEUTICALS, INC. - INO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.2% | 6,190,475 | View |
| May 13, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.84% | 4,233,529 | View |
| May 13, 2026 | SCHEDULE 13G/A | Robert Atchinson | 5.84% | 4,233,529 | View |
| May 13, 2026 | SCHEDULE 13G/A | Phillip Gross | 5.84% | 4,233,529 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 13.5% | 9,339,614 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 13.5% | 9,339,614 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Alyeska Investment Group, L.P. | 5.99% | 4,000,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Alyeska Fund GP, LLC | 5.99% | 4,000,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Anand Parekh | 5.99% | 4,000,000 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 4.96% | 3,315,579 | View |
| Dec 08, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 9.99% | 6,666,295 | View |
| Dec 05, 2025 | SCHEDULE 13G | FMR LLC | 14.8% | 9,846,664 | View |
| Dec 05, 2025 | SCHEDULE 13G | Abigail P. Johnson | 14.8% | 9,846,664 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.